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Insulin in the acute renal adaptation to dietary phosphate restriction in
the rat. Dietary phosphate restriction produces a rapid increase in
tubular reabsorption of phosphate. To evaluate whether insulin is
important in the acute renal adaptation following a low phosphate meal,
four groups of conscious rats were studied by renal clearance methods,
following a single meal by gavage. Group A received a normal (0.8%)
phosphate meal, followed by saline infusion; Group B, a low (0.03%)
phosphate meal, followed by saline infusion; Group C, a low phosphate
meal, followed by infusion of somatostatin to suppress endogenous
insulin secretion; and Group D, a low phosphate meal, followed by
infusion of somatostatin plus insulin. Baseline plasma phosphate,
insulin, glomerular filtration rate, and fractional excretion of phosphate
were similar in all four groups. Following a low phosphate meal in
Groups B, C, and D, there was a decrease in plasma phosphate, as
compared with Group A. Whereas fractional excretion of phosphate
decreased when plasma phosphate fell in Group B, administration of
somatostatin (Group C) prevented the drop in fractional excretion of
phosphate, despite a lower plasma phosphate. The addition of exoge-
nous insulin (Group D) restored the antiphosphatunc effect of the low
phosphate meal. These results suggest that insulin contributes to the
acute decrease in phosphate excretion following a low phosphate meal.
The kidney responds to dietary phosphate restriction with an
increase in tubular reabsorption of phosphate (TRP), resulting
in a decrease in urinary phosphate excretion [1—3]. Recent
studies, using both whole animal clearance studies and proxi-
mal tubular brush border membrane vesicle techniques, have
demonstrated that this renal adaptation occurs within two to
four hours of a single low-phosphate meal [4, 5]. The mecha-
nism of this adaptation to phosphate deprivation remains poorly
understood, despite extensive investigation.
Intravenous phosphate infusion into rats maintained on a low
phosphate diet fails to reverse the renal conservation of phos-
phate, despite the attainment of normal or supranormal plasma
phosphate levels [1, 6]. In contrast, intraperitoneal administra-
tion of phosphate restores phosphaturia in dietary phosphate
deprived rats [7]. The observation that the route of phosphate
administration influences the renal response suggests that the
gut or liver may sense the dietary phosphate content and signal
the information to the kidney, perhaps by releasing a hormone
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[81. In response to a phosphate restricted meal, such a hormone
would signal the kidney to increase tubular reabsorption of
phosphate. The putative hormone would have to possess a
rapid onset of action and a short half-life, to effectively respond
to a changing dietary intake in a prompt fashion.
Insulin is an attractive candidate for this putative hormone. It
is predictably secreted in response to meals [91. It decreases
urinary phosphate excretion in fasted rats [101, dogs [11], and
humans [12]. Moreover it increases phosphate uptake by prox-
imal tubular membrane vesicles [13]. The inhibition of insulin
secretion by somatostatin results in enhanced phosphaturia in
fasted rats; this effect is reversed by subsequent exogenous
insulin replacement [101.
The aim of this study was to evaluate whether insulin is an
important regulator of renal phosphate retention during acute
dietary phosphate restriction. The hypothesis was tested by
determining the acute change in urinary phosphate excretion
following a single low phosphate meal in rats. The effect of
inhibition of endogenous insulin secretion on this adaptation
was tested by the infusion of a somatostatin analog following
the meal. The specificity of this effect was then determined by
supplying exogenous insulin along with the somatostatin.
Methods
Male Wistar rats (Charles River Breeding Company, Wilming-
ton, Massachusetts, USA) weighing 300 to 350 grams were
studied. The animals were trained over one week to eat their
entire daily ration during a one hour period each day. This was
accomplished by restricting the availability of food to just one
hour each morning, until the animals consistently ate at least 10
grams of food within that hour, and maintained their weight.
Preliminary studies revealed that from the third day on, the rats
consistently ate about 12 grams of food. The rats lost 4% of
their body weight during the first two days of training, with no
subsequent change for the remainder of the week. During the
training period the animals received normal rat chow (ICN
Biochemicals) containing 0.8% phosphate, 1.0% calcium, 1%
sodium, 20% protein, and 66% sucrose. Water was available ad
jib.
Following the seven day training period, an acute clearance
experiment was performed in awake, unrestrained rats on the
eighth day, after a 24 hour fast. The right femoral artery and
vein were cannulated with PE-lO tubing under light general
anesthesia (sodium pentobarbital, 50 mg/kg). The proximal end
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of each tubing was tunnelled subcutaneously and exteriorized in
the back of the neck. Extension tubings were attached and
inserted through a three channel swivel (Harvard Apparatus). A
blood pressure transducer was connected to the side port of the
arterial extension tubing for continuous blood pressure moni-
toring.
The rat was placed in a metabolic cage (Nalgene') which
allowed accurate collection of urine. A loading dose of 3H-
inulin (ICN Radiochemicals), 2.5 pCi was administered intra-
venously in 5 ml normal saline over 10 minutes. This was
followed by a continuous infusion of normal saline at 4 ml/l00
glhr via a Harvard infusion pump. 3H-inulin was added to the
saline at a concentration calculated to deliver 5 pCi/hr. After a
60-minute equilibration period to allow for the establishment of
a brisk diuresis, a steady-state plasma inulin level, and recovery
from the anesthesia, a baseline blood sample was obtained
througn the arterial catheter. The rat then received 16 ml of
dietary suspension (equivalent to 12 g of powdered diet),
administered by gavage. A 4.5 hour experimental period ensued
following the gavage. Six consecutive clearance periods were
obtained, each lasting between 40 and 50 minutes, and ending
immediately after the rat voided. Using the technique de-
scribed, we had established in preliminary studies that accurate
clearance measurements could be obtained in spontaneously
voiding rats (coefficient of variation for glomerular filtration rate
was 4.8% in 6 spontaneously voiding rats, as compared to 4.5%
in 6 animals with bladder catheterization). Urine samples were
collected in pre-weighed test tubes. Arterial blood was sampled
with heparinized syringes at the end of each clearance period.
Each blood sample was immediately centrifuged, and the
plasma sample frozen for subsequent assays. Continuous blood
pressure monitoring was performed to assure that blood pres-
sure was constant during the experiment.
Four groups of rats were studied.
Group A: Effect of a normal phosphate meal on phosphate
excretion (N = 7)
Clearance experiments were performed following gavage
with a normal (0.8%) phosphate meal, during sustained infusion
with sodium chloride (150 mmol/liter) at a rate of 4 ml/lOO g
wt/hr. This diet was prepared by adding to a low phosphate diet
(ICN Biochemicals) sodium phosphate (4 parts dibasic to 1 part
monobasic) to achieve a 0.8% phosphorus content by weight.
The resulting powder was blended in distilled water to produce
a suspension that could be administered by gavage.
Group B: Effect of a low phosphate meal on phosphate
excretion (N = 7)
Clearance experiments were performed following gavage
with a low (0.03%) phosphate meal, during sustained sodium
chloride infusion. The diet was prepared by adding to the low
(0.03%) phosphate diet (ICN Biochemicals) sufficient sodium
chloride to achieve a sodium content similar to that in Group A.
The powder was blended in distilled water to produce a
suspension that could be administered by gavage.
Group C: Effect of somatostatin on phosphate excretion
following a low-phosphate meal (N = 7)
These animals were studied in an identical fashion to those in
Group B, except that D-Trp8-somatostatin, a potent somato-
statin analog, (Bachem, Torrance, California, USA) was added
to the infusate to deliver 0.3 mg/kg/hr. Preliminary studies had
established that this infusion rate was the minimum needed to
consistently maintain suppression of insulin under these exper-
imental conditions.
Group D: Effect of insulin supplementation on phosphate
excretion during somatostatin infusion following a low-
phosphate meal (N = 6)
This group was studied in an identical fashion to those in
Group C, except that in addition to the D-Trp8-somatostatin,
regular insulin (Lilly Company) was added to deliver 0.4
U/kg/hr. This rate of insulin infusion had been shown in
preliminary studies to produce physiologic concentrations sim-
ilar to those measured in Group B.
Analytic methods
Urine volumes were determined by weighing the timed
collections in the pre-weighed test tubes. All plasma and urine
samples were assayed in duplicate for inulin and phosphate. In
addition, plasma samples were assayed for insulin and glucose.
All urine samples were assayed for sodium. The terminal
plasma samples from each experiment were assayed for sodium
and bicarbonate concentrations. Inulin was measured by a
scintillation counter, phosphate by the spectrophotometric
method of Daly and Ertinghausen [14], sodium by flame pho-
tometry, insulin by radioimmunoassay (ICN Micromedic), and
glucose by the glucose oxidase method (Beckman analyzer).
The insulin assay is 90% cross-reactive with rat insulin. The
glomerular filtration rate was estimated from the inulin clear-
ance, and fractional excretion of phosphate and sodium were
calculated using standard formulae.
Statistical analysis
Statistical differences of parameters within groups were eval-
uated using analysis of variance for repeated measures, fol-
lowed by paired t-tests for specific comparisons. Differences
between groups were tested by analysis of variance, followed
by unpaired t-tests. Since insulin concentrations were not
normally distributed, they were compared by nonparametric
tests, the Kruskall-Wallis test, and the Mann-Whitney two-
sample test. Differences within groups were analyzed by the
Wilcoxon signed ranks test. A P value <0.05 was considered
statistically significant.
Results
Baseline plasma phosphate was similar in all four experimen-
tal groups (Figs. 1, 2). Following the administration of normal
phosphate meals there was a transient, nonsignificant increase
in plasma phosphate for the first ninety minutes, followed by a
gradual decline in this parameter (Fig. 1). In contrast, the low
phosphate diet resulted in a prompt fall in plasma phosphate.
After their respective meals the animals receiving a low phos-
phate diet and saline infusion maintained consistently lower
mean plasma phosphate concentrations than those receiving a
normal diet. There was a sustained increase of fractional
excretion of phosphate in rats receiving a normal diet (Fig. 1).
In contrast, fractional phosphate excretion fell following a low
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Fig. 1. Changes in plasma phosphate and fractional excretion of
phosphate following either a normal (0.8%, S U)or a low (0.03%,
0——C) phosphate diet, Values represent means SEM. B is baseline
value. * P < 0.05 between the two groups for that clearance period.
phosphate meal, and was consistently lower for each clearance
period than the values observed with a normal diet.
The rats receiving a somatostatin infusion following the low
phosphate meal developed more severe hypophosphatemia
than their controls receiving saline alone (Fig. 2). In contrast,
animals receiving somatostatin and exogenous insulin following
a low phosphate meal developed changes in plasma phosphate
similar to those seen in the controls receiving a low phosphate
diet and an infusion of saline alone. The fractional excretion of
phosphate increased in rats infused with somatostatin despite
receiving a low phosphate meal. The exogenous administration
of insulin superimposed on somatostatin infusion resulted in a
fall in fractional excretion of phosphate similar to that observed
in control animals receiving saline alone.
The fractional excretion of phosphate was plotted against
plasma phosphate for the three groups of rats receiving a low
phosphate diet (Fig. 3). In the group receiving a low phosphate
diet plus normal saline, a decrease in plasma phosphate was
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Fig. 2. Changes in plasma phosphate and fractional excretion of
phosphate in the three experimental groups receiving a low (0.03%)
phosphate diet. Values represent means SEM. B is baseline value.
Abbreviations are: LPD, low phosphate diet; NS, normal saline; INS,
insulin; SS, somatostatin. * P < 0.005 vs. the corresponding values in
the other two groups (LPD + NS and LPD + SS + INS) for that
clearance period. Symbols are: (— —C) LPD + NS; (—•) LPD + SS;(-.-A)LPD+SS+ INS.
associated with a significant decrease in the fractional excretion
of phosphate. However, in animals receiving a low phosphate
diet plus somatostatin, a progressive increase in phosphate
excretion was observed despite the decrease in plasma phos-
phate. Exogenous insulin replacement prevented the increase in
phosphaturia associated with infusion of somatostatin alone.
The changes in plasma insulin and glucose in the four groups
are shown (Figs. 4 and 5). Fasting plasma insulin levels were
appropriately suppressed in all four groups (4.8 1.9, 7.3
2.0, 2.2 1.2, and 10.5 5.5 U/m1, respectively, in Groups A
through D). Following both a normal and a low phosphate diet
there was an increase in plasma insulin (Fig. 4). The rise in
plasma insulin was more pronounced following the low phos-
phate diet (Group B), achieving statistical difference in the first
two clearance periods. Plasma insulin levels remained predict-
ably suppressed during the somatostatin infusion at less than 14
U/ml in all clearance periods (Fig. 5). In rats receiving insulin
in addition to somatostatin, plasma insulin levels reached a
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plateau in the physiologic range (average of 45 U/mI in the last
4 clearance periods), similar to that obtained in rats receiving a
low phosphate meal followed by infusion of saline alone.
Fasting plasma glucose was similar in all four experimental
groups (103 3, 123 12, 105 2, 116 2 mgldl, respectively,
in Groups A to D). It rose following both the normal and low
phosphate meals (Fig. 4), but glucose concentrations remained
significantly higher after the low phosphate meal (184 18 vs.
130 4 mg/dl, P < 0.02 in the third clearance period, and 178
13 vs. 146 3 mg/dl, P < 0.05 in the sixth clearance period).
Infusion of somatostatin to rats receiving a low phosphate meal
(Fig. 5) resulted in a sustained elevation of plasma glucose as
compared to animals receiving the same diet followed by saline
infusion (253 31 vs. 184 18 mg/dl, P < 0.02 in the third
clearance period, and 244 25 vs. 178 13 mg/dl, P < 0.03, in
the sixth clearance period). Finally, exogenous insulin replace-
ment resulted in plasma glucose levels similar to those mea-
sured in animals receiving saline alone (141 24 vs. 184 18
mg/dl) in the third clearance period, and 139 31 vs. 178 13
mgldl in the sixth period).
The glomerular filtration rate remained constant over time in
all experimental groups and did not differ among groups during
any clearance period (Table 1). The terminal plasma bicarbon-
ate concentrations did not differ among the four experimental
groups (20.9 0.7, 19.2 2.5, 21.9 1.8, and 20.6 1.0
mmollliter, respectively, for Groups A to D). Fractional excre-
tion of sodium was similar in all four treatment groups (5.76
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Fig. 4. Changes in plasma insulin and glucose following a normal
(0.8%, U) or a low (0.03%, 0) phosphate diet. Values represent means
SEM. B = baseline value. * P < 0.05 between the two groups for that
clearance period.
0.48, 4.44 0.73, 4.78 0.38, and 5.14 0.54% in the sixth
clearance period for Groups A to D, respectively).
Discussion
The acute administration of a low phosphate meal to fasted
rats produced an acute decrease in both plasma phosphate
concentration and in fractional excretion of phosphate, as
previously reported [4, 51. Pharmacologic blockade of endoge-
nous insulin release by somatostatin resulted in an increase in
fractional phosphate excretion, despite an even more marked
hypophosphatemia. Exogenous insulin replacement superim-
posed on somatostatin infusion reversed the excessive urinary
phosphate losses. Taken together, these observations suggest
that insulin plays an important role in the acute renal adaptation
to dietary phosphate deprivation.
The somatostatin analog used in this study nonselectively
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Fig. 3. Fractional excretion of phosphate vs. plasma phosphate plot-
ted for the three experimental groups receiving a low (0.03%) phos-
phate diet. Values represent means SCM. Curves were drawn by
inspection for each group. Abbreviations are in Figure 2. Symbols are:
(0) LPD + NS; (•) LPD + SS; (V) LPD + SS + INS.
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Fig. 5. Changes in plasma insulin and glucose following the meal in
the three experimental groups receiving a low (0.03%) phosphate diet.
Values represent means SEM. Abbreviations are in Figure 2, Symbols
are: (—---0) LPD + NS; (—•) LPD + SS; (—.
—A) LPD + SS + INS.
* = P < 0.05 vs. the corresponding values in the other two groups (LPD
+ NS and LPD + SS + INS) for that clearance period.
inhibits the release of insulin, glucagon, and growth hormone
[15]. Evidence is available to suggest that each of the three
hormones may affect tubular reabsorption of phosphate. Stud-
ies in both dogs [16] and humans [17] have demonstrated an
increase in tubular reabsorption of phosphate following growth
hormone administration. While growth hormone receptors have
been identified in the kidney [18], the changes observed in the
present study were too rapid to be explained on the basis of
somatomedjn production stimulated by growth hormone [19].
The pancreatic hormone, glucagon, is known to produce phos-
phaturia when administered to dogs [201, mice [21], rats [22],or
humans [23]. This appears to be a direct effect, since it is
reproduced by infusion of glucagon into the renal artery [24].
Insulin, on the other hand, results in decreased phosphate
excretion by the kidneys in fasted rats [10], dogs [11], and
humans [12]. Insulin increases phosphate uptake by proximal
tubular membrane vesicles [13]. Moreover, insulin can reverse
[25] or prevent [26] the phosphaturic effect of parathyroid
hormone, suggesting that insulin may have a physiologic role in
the acute renal handling of phosphate.
Given glucagon's known phosphaturic action, it is unlikely to
be responsible for acute phosphate retention by the kidney. It is
also conceivable that somatostatin per se may have a renal
tubular effect independent of its effects on other hormones. The
restoration of avid phosphate reabsorption by exogenous insu-
lin, however, implicates insulin in the acute renal adaptation to
dietary phosphate restriction.
The contribution of additional factors to renal phosphate
handling in this experimental model must be considered. Vol-
ume expansion is known to inhibit phosphate reabsorption by
the kidney [27]. The phosphaturic effect of this maneuver is
blunted, however, in animals maintained on a low phosphate
diet [27]. Moreover, all experimental groups in the current
study received a similar degree of volume expansion, so that
this maneuver would be expected to have a similar impact in all
animals studied,
Tubular reabsorption of phosphate changes in response to
changes in filtered load of phosphate, rather than in plasma
phosphate. In the absence of any observed change in GFR
during the course of the experiments (Table 1), however,
changes in the filtered load of phosphate directly mirrored
changes in plasma phosphate. There was, in fact, an increase in
phosphate excretion despite a decrease in filtered load of
phosphate in the group receiving somatostatin. This observa-
tion suggests that in this experimental setting renal phosphate
retention may actually be signaled by a factor independent of
filtered phosphate load.
The administration of somatostatin resulted, not only in the
inhibition of insulin secretion, but also in a sustained hypergly-
cemia in response to the meal. Conceivably, the hyperglycemia
per se might decrease phosphate reabsorption by producing an
osmotic diuresis. However, the degree of hyperglycemia ob-
served is not in the range associated with such a phenomenon
[28].
Insulin may have a mild antinatriuretic effect on the kidney
[11], that could conceivably affect phosphate excretion. The
rates of sodium excretion were not different, however, among
the four experimental groups at any clearance period. Insulin-
openia may cause metabolic acidosis due to production of
ketoacids, and acidemia, in turn, may produce phosphatuna
[29]. However, the terminal plasma bicarbonate concentration
was not different in the animals receiving somatostatin infusion.
Moreover, the phosphaturia due to metabolic acidosis is asso-
ciated with hyperphosphatemia [29], whereas it was associated
with hypophosphatemia in the rats infused with somatostatin.
Whether the participation of insulin in renal phosphate reten-
tion following an acute low phosphate meal is a direct effect or
an indirect effect mediated by a second hormone cannot be
determined from the present study. Insulin secretion was also
stimulated following a normal phosphate diet, without resulting
in renal phosphate retention. Plasma insulin levels were how-
ever, significantly higher in the rats receiving a low phosphate
meal than in those fed a normal meal. This elevation may have
enhanced the uptake of phosphate by the proximal tubular cells.
The increased plasma glucose concentration in the face of
higher insulin levels suggests an insulin resistance related to a
low phosphate meal, as there is no evidence to suggest that a
I I I I I
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Table 1. Glomerular flutration rates (mi/mm) in the experimental groups
Clearance period
1 2 3 4 5 6
Group A 2.78 0.13 2.90 0.15 2.77 0.15 2.92 0.14 2.84 0.17 2.77 0.38
Group B 2.93 0.13 3.10 0.19 2.84 0.24 2.64 0.21 2.79 0.19 2.89 0.22
Group C 3.02 0.35 3.13 0.30 3.10 0.26 3.10 0.18 3.23 0.25 3.14 0.22
Group D 3.18 0.06 3.14 0.22 2.94 0.20 3.05 0.16 2.97 0.16 3.05 0.17
low phosphate meal has a more rapid intestinal absorption than
does a normal phosphate meal. This apparent insulin resistance
is in agreement with a previous report of a blunted hypoglyce-
mic response to insulin in chronically hypophosphatemic dogs
[30]. The resistance to the hypoglycemic effect of insulin does
not necessarily carry over to other metabolic effects of insulin,
such as antiphosphaturia. Thus, the marked increase in insulin
after a low phosphate meal may be a physiologic factor con-
tributing to the retention of phosphate by the kidney.
In vitro studies have demonstrated a rapid increase in sodi-
um-dependent phosphate uptake by LLC-PK1 cells within one
hour of incubation in a phosphate-free medium [31]. While
these observations suggest a direct adaptation to the phosphate
concentration, they do not mitigate against an additional con-
tribution of insulin to phosphate uptake. Moreover, since the
culture medium in these experiments includes insulin, one
cannot rule out a role for this hormone in the observed
adaptation to phosphate deprivation.
A physiologic role for insulin in renal phosphate retention
following dietary phosphate retention is consistent with several
previous observations. Both insulin and dietary phosphate
restriction are known to independently stimulate tubular reab-
sorption of phosphate in the presence or absence of parathyroid
hormone (PTH) [3, 25]. Both prevent the phosphaturic effect of
PTH [2, 26]. Renal production of calcitriol is increased both by
insulin and by dietary phosphate depletion [32, 33]. Moreover,
insulinopenia inhibits the production of calcitriol during dietary
phosphate restriction [34], by blunting the stimulation of 1-
a-hydroxylase activity in the proximal tubule [35]. Calcitriol in
turn may acutely enhance renal phosphate retention [36]. Taken
together, these observations suggest that insulin contributes to
the acute decrease in phosphate excretion following a low
phosphate meal.
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